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Mammary extracellular matrix
directs differentiation of testicular
and embryonic stem cells to form
functional mammary glands in vivo
Robert D. Bruno1,*, Jodie M. Fleming2,*, Andrea L. George3, Corinne A. Boulanger3,
Pepper Schedin4 & Gilbert H. Smith3
Previously, we demonstrated the ability of the normal mammary microenvironment (niche) to direct
non-mammary cells including testicular and embryonic stem cells (ESCs) to adopt a mammary epithelial
cell (MEC) fate. These studies relied upon the interaction of transplanted normal MECs with nonmammary cells within the mammary fat-pads of recipient mice that had their endogenous epithelium
removed. Here, we tested whether acellular mammary extracellular matrix (mECM) preparations are
sufficient to direct differentiation of testicular-derived cells and ESCs to form functional mammary
epithelial trees in vivo. We found that mECMs isolated from adult mice and rats were sufficient to
redirect testicular derived cells to produce normal mammary epithelial trees within epithelial divested
mouse mammary fat-pads. Conversely, ECMs isolated from omental fat and lung did not redirect
testicular cells to a MEC fate, indicating the necessity of tissue specific components of the mECM.
mECM preparations also completely inhibited teratoma formation from ESC inoculations. Further, a
phenotypically normal ductal outgrowth resulted from a single inoculation of ESCs and mECM. To the
best of our knowledge, this is the first demonstration of a tissue specific ECM driving differentiation of
cells to form a functional tissue in vivo.
Understanding the microenvironmental factors that control cell function, differentiation, and stem cell renewal
are at the crux of developmental and cancer biology. In recent years, our laboratory has explored the capacity of
the local mammary microenvironment (niche) to control the cellular fate and differential potential of cells1–9.
Our previous reports have found that the regenerating mouse mammary gland can re-direct testicular cells1,
neural stem cells2, bone marrow5, and breast cancer cells3,4 to adopt a normal mammary progenitor cell fate.
Further, we found that the mammary microenvironment can suppress teratoma formation and direct differentiation of mouse embryonic stem cells (ESCs)7 and human teratocarcinoma (Ntera-2) cells3 to a mammary epithelial
cell fate in vivo. In all cases, the redirected non-mammary or cancer-derived cell types continued to proliferate
and self-renew, persisting through multiple transplant generations. All of these studies were performed with
essentially the same experimental design: dispersed normal mouse mammary epithelial cells were mixed with
non-mammary or cancer cells and inoculated into the cleared mammary fat-pad of a recipient mouse. Our interpretation of this is that the non-mammary and cancer-derived cells are incorporated into mammary niches, due
to cell-cell interaction, as these locations are formed by the dispersed MECs during growth. Once incorporated,
they adopt a normal mammary cell fate and contribute mammary progeny to the outgrowth. These studies underscore the dominance of the mammary locale (niche) in determining cell fate in the mammary gland. However, the
nature and composition of the mammary niche(s) remains elusive.
The extracellular matrix (ECM) is a key component of the cellular microenvironment. More than just
a scaffold of support proteins, the ECM is tethered with diverse signaling molecules that show tissue-specific
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patterning10,11. In the mammary gland, the ECM is dynamic, changing in both composition and structure with
pregnancy, lactation, and involution12. ECM has a role in stem cell renewal and differentiation both in vivo and
in vitro, and thus is likely an important mediator of the mammary stem cell niche.
Here, we tested the hypothesis that mammary ECM contains factors that are integral components of the
mammary niche and thus sufficient to direct differentiation of non-mammary cells in the context of the mammary fat-pad. Specifically, we tested if mammary ECM (mECM) extracts would be sufficient (in the absence of
normal MECs) to direct the differentiation of testicular and ESCs to MECs when transplanted into a cleared
mammary fat-pad. Testicular cells were sourced from WAP-CRE/Rosa26-loxp-stop-loxp-LacZ (WC/R26LacZ)13.
These mice have been previously described to mark a particular progenitor population termed parity identified
mammary epithelial cells (PI-MECs) following pregnancy and involution6,14–16. Briefly, activation of the whey
acidic protein (WAP) promoter during pregnancy induces CRE expression which in turn removes a premature
floxed stop-codon causing irreversible and constitutive β-galactosidase (β-gal) expression from the Rosa26-LacZ
locus. PI-MECs are found among a fraction of luminal cells within secondary and tertiary ducts, and function
as lobular progenitors in subsequent pregnancies14,15. The ESCs used here were isolated from Rosa26-LacZ mice,
and constitutively express β-gal in all cell types17,18. These two reporters allowed us to identify the exogenous cell
sources in resulting transplants by 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) staining. mECM
was isolated from mammary glands of adult female nulliparous mice, as well as nulliparous and involuting rats.
We identified X-gal+outgrowths in a total of 26/99 mammary glands inoculated with testicular cells and mECM
across all conditions. The outgrowths displayed normal mammary gland morphology and milk protein production. Conversely, ECM from omental fat or lung were incapable of directing testicular cells to form mammary
outgrowths. We also found that mECM eliminated teratoma formation of ESCs and resulted in an X-gal+ outgrowth in a single case. The resulting outgrowth demonstrated cytokeratin and hormone receptor expression.
These results demonstrate that the non-cellular mECM fraction of the mammary gland contains critical factors
of the mammary niche that, in conjunction with the mammary fat-pad, are sufficient to direct non-mammary
cells to a mammary epithelial cell fate. These findings are, to the best of our knowledge, the first demonstration of
the capacity of adult tissue specific ECM to mediate the direct differentiation of stem cells and inhibit teratoma
formation in vivo.

Results

Mouse mammary ECM (mECM) redirects testicular cells to adopt a normal mammary epithelial
cell fate. Cells isolated from the testes of WC/R26Lacz mice were the first to be shown to respond to signals

within the regenerating mouse mammary gland to adopt a normal mammary epithelial progenitor cell fate1.
To advance these findings, we tested whether physical contact with mammary epithelial cells was required, or
whether the soluble and structural constituents of the mECM were sufficient to redirect testicular cells to a mammary epithelial cell fate. 7.5 ×  104 mouse testicular cells were injected with or without soluble mECM isolated
from adult nulliparous female BALB/c mice into the cleared mammary fat pads of recipient female nude mice.
Following pregnancy and involution, whole mount and cross-section imaging of mammary glands revealed normal X-gal+mammary epithelial outgrowths in 16/62 inoculations with mECM (Table 1; Fig. 1A–D). Importantly,
the pattern of X-gal staining was consistent with the expected distribution of PI-MECs in intact WC/R26-LacZ,
suggesting normal activation of the Wap promoter. Consistent with previous results1, inoculations of testicular
cells in vehicle (DMEM) did not generate mammary outgrowths (0/15; Table 1). Further, no Xgal+ outgrowths
were observed when testicular cells were inoculated with matrigel (not shown) or with ECM isolated from omental fat (0/14) or lungs (0/19) of adult mice (Table 1). The difference in rate of outgrowth formation between inoculations of testicular cells with mECM or with omental fat ECM, lung ECM or vehicle (DMEM) was statistically
significant (p =  0.0327; p = 0.0173, and p = 0.0326, respectively). Therefore, the factors critical for the differentiation of the testicular cells to MECs are specific to mECM. We identified the presence of the Y chromosome by
fluorescent in situ hybridization (FISH) and PCR in the outgrowths, confirming they were derived from the testicular cells and not ingrowth of endogenous epithelium (Fig. 1E and F). Furthermore, inoculations of the cleared
fat pads with mECM alone did not induce outgrowths (0/10; Table 1) or notable changes to the adipose/stroma.
It is important to note that positive X-gal staining under these experimental conditions is only seen in the
mammary gland upon exogenous expression of β-gal13,19. Exogenous β-gal expression could only come from the
transplanted testicular cells. Further, to express β-gal, the testicular cells must have activated the mammary specific WAP promoter during pregnancy and subsequently survived involution. This is consistent with the interpretation that the testicular derived cells had differentiated into fully functional mammary epithelial cells including
PI-MECs.
To determine if the testicular-derived epithelial trees were capable of normal MEC function, fragments taken
from first generation outgrowths were transplanted into cleared mammary fat pads of new hosts and the mice
were mated to induce lactogenic differentiation. At 14 days of pregnancy, glands were removed and cross sectioned. Staining with antibodies specific for the milk proteins alpha-lactalbumin and caseins revealed normal
milk protein production and luminal secretion, consistent with normal mammary epithelial cell function (Fig. 1G
and H). The glands also expressed the basal myoepithelial cell marker smooth muscle actin alpha (SMA; Fig. 1I)
and the hormone receptor ERalpha (ERα; Fig. 1J) in the correct orientations. Combined, these results demonstrate that the testicular derived cells had made a fully functional mammary epithelial tree upon transplantation
with mECM.

mECM from both nulliparous and involuting rats redirect testicular cells to adopt a normal
mammary epithelial cell fate. Following these initial observations, we next turned to mECM isolated

from Sprague-Dawley rat mammary tissues. Rat mammary epithelial cells grow normally in mouse fat pads and
mouse cells respond to rat mECM12,20. Rat tissue is advantageous because of the greater concentrations of mECM
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Cell Source

Treatment

Xgal+ mammary outgrowth/ Xgal+ second generation
total inoculations
outgrowths inoculations

7.5 ×  104 Testicular Cells Nulliparous Mouse mECM

16/62

ND

7.5 ×  104 Testicular Cells

Omental Fat ECM

0/14

N/A

7.5 ×  104 Testicular Cells

Lung ECM

0/19

N/A

7.5 ×  104 Testicular Cells

DMEM

0/15

N/A

Nulliparous Mouse mECM

0/10

N/A

5 ×  104 Testicular Cells

Nulliparous Rat mECM

4/18

5/8

5 ×  104 Testicular Cells

Involuting Rat mECM

6/19

ND

5 ×  104 Testicular Cells

DMEM

0/20

N/A

None

Table 1. Transplantation results for WC/R26-LacZ testicular cells with mECM. Cell/ECM mixtures were
inoculated into the epithelium divested (cleared) mammary fat-pads of 3–4 week old female nude mice. Mice
were impregnated and allowed to involute for 3 weeks to activate the WC/R26-LacZ reporter. Second generation
outgrowths were generated by transplanting fragments from Xgal+primary outgrowths into cleared mammary
fat-pads of 3–4 week female nude old mice and allowed to grow for 8 weeks. ND = not determined; N/A =  not
applicable.

that can be produced from the larger rat glands. 5 ×  104 WC/R26-LacZ mouse testicular cells were injected with
or without soluble mECM from nulliparous or involuting female rats into the cleared mammary fat-pad of nude
recipient female nude mice. As previously reported1, 5 ×  104 testicular cells never formed glands when inoculated alone (0/20; Table 1). Both nulliparous ECM and involuting ECM preparations were used because previous
studies have identified differences in their content and stimulatory effects on breast cancer cells21,22. Following
pregnancy and involution, whole mount and cross-section imaging of mammary glands revealed normal X-gal+
mammary epithelial outgrowths in 4/18 inoculations with nulliparous mECM (p = 0.0415 vs testicular cells
alone) and 6/19 inoculations with involuting mECM (p = 0.0083 vs. testicular cells alone; Fig. 2; Table 1). There
was no statistical difference in the effect of involuting mECM vs nulliparous mECM (p =  0.7140).
An important feature of the mouse mammary gland is the capacity of any portion of the epithelial tree to
regenerate a functional mammary tree upon transplantation23. To determine if the testicular/mECM derived
outgrowths retained this capacity, we transplanted fragments from first-generation outgrowths resulting from
inoculation of testicular cells and nulliparous mECM into cleared mammary fat-pads and stained the resulting
glands with X-gal. 5/8 transplants resulted in mammary outgrowths that contained X-gal+cells, with the remaining 3 not forming any outgrowth (Fig. 2I and J; Table 1). This is consistent with previous results that demonstrated that non-mammary cells redirected to a MEC fate by the mammary microenvironment could contribute
to second-generation outgrowths2,5,7,16. Presence of the X-gal+cells in second generation outgrowths demonstrates that the β-gal+testicular derived cells were not terminally differentiated, but capable of self-renewing and
undergoing extensive proliferation to regenerate the gland.

Mammary ECM extracts inhibit teratoma formation and direct differentiation of mouse ES
cells to mammary epithelial cells in cleared mammary fat-pads. We next sought to determine if

pluripotent ESCs could similarly be directed to a MEC fate by inoculation with mECM into cleared mammary
fat-pads. We injected 1 ×  103 or 1 ×  104 Rosa26-LacZ ESCs (which constitutively express β-gal) with or without
involuting ECM. As previously reported7, Rosa26-LacZ ESCs formed teratomas in all cases when inoculated
in vehicle (DMEM) alone (Table 2). However, in the presence of mECM, none of the ESC inoculations formed
teratomas (Table 2). This reduction in teratoma formation by mECM is statistically significant (p =  0.0079) for
both cell injection numbers (1 ×  103 and 1 ×  104). Further, 1/5 inoculations of 1 ×  103 Rosa26-LacZ ESCs formed
a mammary epithelial outgrowth that stained positive for X-gal (Fig. 3A). Cross sections demonstrated that the
Xgal+cells were present throughout the ductal tree in nearly all cells (Fig. 3B and C), as expected for the constitutive Rosa26-LacZ reporter.
To further verify the mammary epithelial tree consisted of the transplanted Rosa26-LacZ ESCs and did not
result from ingrowth of endogenous cells, we performed PCR on DNA isolated from the outgrowth to detect the
Rosa26-LacZ locus (Fig. 3D). Primers specific for the Rosa26-LacZ locus amplified DNA in the X-gal positive
outgrowth shown in Fig. 3A but not in control mouse glands. Further, primer sets specific for rat DNA confirmed
no contamination of rat MECs within the mECM.
Finally, we immunostained the resulting mammary outgrowth to determine if the ESCs had differentiated into
all the major epithelial cell types of the mammary gland. The outgrowth stained positive with a pan-cytokeratin
antibody (Fig. 4A and B) although the staining lacked uniformity as usually seen in normal mammary tissues
(Fig. 4C). Similarly, staining with an antibody specific for the luminal marker cytokeratin 8 (Fig. 4D and E)
demonstrated the presence of CK8 cells with a lack of uniformity compared to control glands (Fig. 4F).
Conversely, normal staining confined to the basal layer was seen with the basal marker SMA (Fig. 4G). Further,
ERαand progesterone receptor (PR) positive and negative cells were seen throughout the luminal layer of the
ESC-derived gland (Fig. 4H and I). The reason for the punctate staining pattern of the cytokeratins is unknown.
It could either be a result of incomplete differentiation of some of the ESC-derived cells or an artifact of the
sample preparation. The normal staining seen in a control sample within the same block argues against the latter
interpretation, however. Regardless, these results demonstrate that the Rosa26-LacZ derived ESCs were capable
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Figure 1. Testicular cells form normal mammary outgrowths in vivo when transplanted with mouse mECM.
7.5 ×  104 testicular cells derived from WC/R26-LacZ mice were inoculated in suspensions of mECM, omental fat
ECM, lung ECM, or vehicle (DMEM) into cleared mammary fat-pads of female nude mice. Following full-term
pregnancy and 3 weeks of involution to activate the WC/R26-LacZ reporter in the testicular-derived cells, glands
were isolated for analysis. (A–C) Examples of X-gal+whole mounts from inoculations of testicular cells and
mECM. X-gal+outgrowths were not seen in any of the testicular cells + control (omental fat ECM, lung ECM, and
DMEM) groups. (D) Cross-section of a an X-gal stained gland derived from testicular cells. X-gal stain is blue,
nuclei are counterstained with nuclear fast red. (E) FISH analysis of testicular derived outgrowths with probes to
the X-chromosome (magenta; left panel) and Y chromosome (green, right panel). (F) PCR with primers specific
for the Y chromosome. Lane 1: Molecular weight marker; Lane 2, 4, and 5: Testicular cells +  mECM outgrowth;
Lane 3: Testicular cells + mECM inoculated fat pad with no outgrowth; Lane 6: water; Lane 7&8: MEC +  mECM
outgrowths; Lane 9&11: outgrowth derived from MEC + testicular cells; Lane 10: MEC + testicular cell inoculated
fat pad with no outgrowth; Lane 12: MEC cells; Lane 13: Testicular cells. (G–J) IHC staining for alpha-lactalbumin
(G), caseins (H), smooth muscle actin (I), and ERα (J) in outgrowth of testicular cells and mECM in 14 day
pregnant host (nuclei counterstained with haematoxylin). Scale bars: A–C = 2 mm; D =  200 μM; E =  100 μM; GI =  100 μM; J =  200 μM.

of differentiating into all of the major mammary epithelial cell types when injected along with mammary ECM
into the cleared mammary fat-pad.

Discussion

While a great deal of focus has been paid to the identification and characterization of somatic cells with stem cell
characteristics, we continue to lack a basic understanding of how heterogenous lineages of cells are generated
and maintained in vivo. Our recent work has demonstrated that in the mammary gland, the components of the
microenvironment (i.e. niche) are the ultimate determinant of cell function, regardless of the original nature of
the stem/progenitor cells within the system. Here we extend these observations by demonstrating that the acellular mECM fraction of the gland contains key components of the niche that are sufficient to direct differentiation
of non-mammary cells to a MEC fate in the context of the mammary fat-pad in vivo. In the case of the testicular
derived cells, they had all of the attributes associated with normal MECs, including the capacity to make milk proteins (Fig. 1G and H) and persist through second-generation outgrowths (Fig. 2I and J). This is important because
it demonstrates the signaling effect of the mECM is not to terminally differentiate the cells, but rather assist in
the organization of the cells into fully functional mammary niches, capable of supporting all aspects of gland
development and function. One important distinction between the present study and our previous publications
is that the non-mammary cells were able to differentiate and form the entire functional mammary gland without
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Figure 2. Testicular cells are directed to MECs by both nulliparous and involuting rat mECM in vivo.
5.0 ×  104 testicular cells from WC/R26-LacZ mice were inoculated in suspensions of nulliparous rat mECM,
involuting rat mECM, or vehicle (DMEM) into cleared mammary fat-pads of female nude mice. Following
full-term pregnancy and 3 weeks of involution to activate the WC/R26-LacZ reporter in the testicular-derived
cells, glands were isolated for analysis. (A–D) X-gal stained whole mounts (A and C) and cross-sections
(B and D) of mammary outgrowths derived from testicular cells and nulliparous rat mECM. (E–H) X-gal
stained whole mounts (E and G) and cross-sections (F and H) of mammary outgrowths derived from testicular
cells and involuting rat mECM. (I and J) X-gal stained whole mount (I) and cross-section (J) of secondgeneration outgrowth derived from transplantation of tissue fragments of primary outgrowths of testicular cells
and nulliparous mECM. X-gal+stain is blue. All cross-sections are counterstained with nuclear fast-red. Scale
Bars: A,C,E,G and I = 2 mm; B,D,F, and H =  200 μM; J =  400 μM.
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Xgal+ mammary outgrowth/
total inoculations

Teratoma/total
inoculations

Cell Source

Treatment

1 ×  103 ESCs

Involuting Rat mECM

1/5

0/5

1 ×  103 ESCs

DMEM

0/4

4/4

1 ×  104 ESCs

Involuting Rat mECM

0/5

0/5

1 ×  104 ESCs

DMEM

0/4

4/4

Table 2. Transplantation results for R26-LacZ ESCs with mECM. Cell/ECM mixtures were inoculated into
the epithelium divested (cleared) mammary fat-pads of 3–4 week old female nude mice. Glands were allowed
to grow for 12 weeks. Differences in teratoma formation rates between mECM and vehicle (DMEM) treatments
were significant (p = 0.0079) for both cell injection numbers (1 ×  103 and 1 ×  104).

Figure 3. Normal mammary outgrowth derived from ESCs and involuting rat mECM. In 1/5 inoculations of
1 ×  103 R26-LacZ ESCs and involuting rat mECM a morphologically normal x-gal+mammary outgrowth was
observed. (A–C) X-gal+whole mount (A) and cross-sections (B and C) of ESC-derived mammary outgrowth.
(D) PCR analysis using primers specific for LacZ gene, rat actin, and mouse chromosome 1 (positive control) in
the outgrowth shown in A–C. Lane 1 = R26-LacZ mouse tail DNA; Lane 2: WT Balb/c mouse tail DNA; Lane 3:
ESC + ECM outgrowth DNA; Lane 4: Water; Lane 5: WT Balb/c mouse tail DNA; Lane 6: Rat LA-7 cell DNA;
Lane 7: ESC + mECM outgrowth DNA; Lane 8: Water. Results confirm outgrowth is comprised of R26-LacZ
mouse ESC-derived cells. Scale Bars: A =  1.5 mm; B =  100 μm; C =  200 μm.

assistance from bona fide MECs. This in itself is remarkable because it indicates that all the signals necessary to
form a functional mammary epithelium in a competent mammary fat-pad are present in the “ECM’ preparations
from intact mammary glands.
The other major finding of this work is that mECM from involuting mammary glands significantly reduced
teratoma formation by the ESCs (Table 2). In fact, under our conditions, teratoma formation was completely eliminated. This is in contrast to previous publications demonstrating pro-tumorigenic affects of involuting mECM
on breast cancer cells22. This difference may be due to differential effects of mECM on pluripotent ESCs versus
breast cancer cells, with the former potentially responding by differentiation and/or apoptosis to the presence
of the mECM. It should be noted, no evidence of differentiation of ESCs—that is presence of X-gal+ cells—was
seen in the fat-pads of the nine inoculations that did not form teratomas or mammary outgrowths. This suggests
that the ESCs had not survived the 12 weeks in vivo. However, the presence of a small amount of ESCs cannot be
ruled out.
The mechanism(s) by which mECM mediates the suppression of teratoma formation and the differentiation
of testicular and ESCs to mammary epithelial cells is currently unknown. Two possibilities exist: 1. The mECM
directly induces the differentiation of the non-mammary cells to MECs, which in turn communicate with the
stromal fat-pad environment to develop into a mammary epithelial tree; 2. The mECM activates signaling within
the stromal fat-pad environment to produce signals that direct the differentiation of the non-mammary cells to
differentiate to MECs. The latter is more likely, but future studies should determine the direct effects of mECM
on both the non-mammary cells (outside of the mammary fat-pad) and the stromal cells within the mammary
fat-pad. Further, specific components of the mECM preparations should be evaluated to determine the critical
elements of the mECM. Because the low frequency of gland formation with both testicular and ESC inoculations
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Figure 4. Expression of MEC proteins in ESC-derived mammary outgrowth. (A–C) Cross-sections of ESCderived outgrowth (A and B) and control gland (C) were stained with a an an anti-pan-cytokeratin antibody.
(D–F) Cross-sections of ESC-derived outgrowth (D and E) and control gland (F) were stained with an anticytokeratin 8 antibody. (G–I) ESC derived mammary outgrowth stained with an anti-SMA (G), anti-ERα (H),
and anti-progesterone receptor (I). X-gal stain is seen in blue. Sections are counterstained with haematoxylin.
Scale bars: A, D, and G =  200 μM; B,C,E,F,H and I =  100 μM.
with the soluble mECM preparations used, future studies should also evaluate the effect of different mECM
preparations (e.g. pepsin digestion) that result in differential protein compositions and structures. Future studies
might also evaluate the effect of different mECM preparations after pretreatment with proteases or nucleases to
help evaluate the nature of the active substances.
Given the wealth of literature showing the unique proteinaceous composition of the mammary ECM, which
also alters during distinct developmental stages12,20,24–28, pinpointing the exact molecules and the orchestration of
signaling between the stroma and parenchyma to direct cell behavior is a challenge. ECM isolated from nulliparous rats has been shown to promote the formation of epithelial ducts with bifurcation, while matrix isolated from
mid-involuting mammary glands induced cell death. ECM isolated from late-stage involuting glands restored
glandular development, and ECM isolated from parous animals restricted glandular morphogenesis12. Our studies support this work by demonstrating both nulliparous and late-stage involuting ECM promote growth and
reprogramming of testicular and embryonic cells to mammary epithelial cells. Collectively, these studies highlight
that hormones, cytokines, and growth factors all influence ECM composition including collagen organization and
stiffness, to affect mammary cell behaviors such as organization and function of integrins and the expression of
cell-cell junction proteins and matrix metalloproteinases25. Critical to data presented within, recent studies suggest that it is not individual molecules, but the relative abundance and organization of the ECM molecules that
dictate tissue function and regulation of cell fate. For example, Goddard et al. demonstrated that the mammary
gland and liver have the same ECM components, but distinct abundance and relative composition of individual
protein components28. Ultimately, both mechanical and biochemical aspects of the soluble and insoluble ECM
must be integrated to understand the collective function. Therefore, the mechanism(s) governing ECM mediated control over cell fate determination are likely to be complex, and not governed by single “magic bullet”
components.
Regardless of the mechanism(s), these findings have potentially major implications for our understanding of
stem cell biology, cancer biology, and regenerative medicine. The mammary niche is composed of both mammary
epithelial cells and the stromal microenvironment of the mammary fat-pad9,23. Together, this niche is sufficient to
direct fate determination of non-mammary and cancer cells to make a functional mammary epithelial tree. The
results outlined here demonstrate that the mECM is a key mediator of the niche. The experimental protocol can
be used to test individual components of the mammary niche and shed light on mediators of normal development
and cancer. Finally, the ability to of the mECM to reduce teratoma formation and potentially direct differentiation
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of pluripotent cells could benefit regenerative medicine applications, particularly to mitigate fears of teratoma
formation in clinical applications.
These studies demonstrate that mammary epithelial cells are dispensable for the redirection of non-mammary
cells to adopt a MEC fate in vivo. Further, the signaling required to redirect testicular cells to a MEC fate are
specific to mECM, as ECM isolated from omental fat or lung failed to mediate lineage conversion. To our collective knowledge, this is the first demonstration that cell fate may be altered in vivo by tissue specific ECM. The
significance of this observation is that it opens the possibility of altering cell fate decisions in vivo without the use
of cells or chemicals and has an important potential role in the control and prophylaxis of mammalian cancers
in situ. The results allow for mechanistic dissection of key elements of the mammary microenvironment and
have important implications for our understanding of developmental biology, cancer, and regenerative medicine.

Methods

Animal Models.

All methods were performed in accordance with the NIH Guide for the Care and Use of
Laboratory Animals. The National Cancer Institute (NCI) Animal Care and Use Committee approved all experimental procedures. Mature BALB/c and Sprague Dawley rats were used as donor mice to obtain ECM extracts.
Female, 3-week-old athymic Nu/Nu mice were used as hosts for transplant studies (NCI Animal production area;
Frederick, MD).

Cell Isolation.

Testicular cells were isolated from adult male WAP-CRE/Rosa26-loxp-stop-loxp-LacZ (WC/
R26LacZ) mice as previously described1,8. Isolated testicular cells were inoculated immediately following isolation. Cells were counted by hemacytometer and diluted in appropriate volumes of either soluble mammary ECM
or plain Dulbecco’s Modified Eagle Medium (DMEM).
ESCs isolated from the Rosa26-LacZ mouse were a kind gift from Philipe Soriano17,18. Cells were cultured as
previously described 7. For all experiments, frozen vials of ESCs were rapidly thawed immediately before inoculation in vivo.

ECM Isolation.

Acellular extracts were performed as described previously 12 . Briefly, mice/rats
were euthanized and the desired tissues were immediately removed, pulverized and extracted with a
high-salt/N-ethylmaleimide solution [3.4 M NaCl, 50 mM Tris-HCl (pH 7.4), 4 mM EDTA-Na2, and 2 mM
N-ethylmaleimide] containing a protease inhibitor cocktail at 4 °C. Homogenates were pelleted at RCFmax
110,000× g for 30 min at 4 °C, and then washed three times in the high salt buffer. The ECM-enriched pellets
were resuspended in a mid-level salt/urea solution [2.25 M urea, 0.2 M NaCl, 50 mM Tris-HCl (pH 7.4), 4 mM
EDTA-Na2, and 2 mM N-ethylmaleimide] with protease inhibitors and extracted overnight at 4 °C. Samples were
pelleted at RCFmax 17,000× g, and the ECM-enriched supernatants were extensively dialyzed (Mr 12,000–14,000
molecular weight cutoff; Spectrum) against a low-salt buffer [0.15 M NaCl, 50 mM Tris-HCl (pH 7.4), and 4 mM
EDTA-Na2], followed by dialysis against serum-free DMEM:F-12 media supplemented with 1 μg/ml gentamicin
at 4 °C. Protein content was measured via Bradford assay. Samples were standardized to equal protein concentrations (mouse ECM =  100 μg/ml; Rat mECM =  300 μg/ml).

Mammary fat-pad clearing and cell inoculation. Mammary fat pad clearing was performed on female
nude mice between 3 and 4 weeks of age as previously described1,7,29,30. Briefly, mice were anesthetized and endogenous epithelium was removed from the #4 and #9 inguinal fat pads by surgically excision of the proximal portion (from the nipple to the lymph node) of the gland. 5 ×  104 or 7.5 ×  104 freshly isolated testicular cells were
then inoculated in 10 μl of ECM or plain DMEM (control) into the cleared mammary fat-pad using a Hamilton
syringe. After staples were removed 2 weeks post-operation, the recipient mice were mated to activate the WC/
R26-LacZ reporter. Following parturition, the pups were euthanized and the mice were allowed to involute for 3
weeks prior to collection of the glands. For ESC transplants, 1 ×  103 or 1 ×  104 R26-LacZ ESCs were inoculated
into cleared mammary fat-pads as described above for testicular cells. Glands were removed after 12 weeks (without mating). All glands were then excised and fixed in 4.0% paraformaldehyde for 2 hrs prior to X-gal staining.
Outgrowth and tumor formation rates were compared statistically by Fisher’s Exact Test.
X-Gal Staining and Immunohistochemistry. X-gal staining and whole mounting of mammary glands
was carried out as previously described1,7,13. #3 and #8 thoracic glands from the recipient nude mice were used
as negative staining controls for all X-gal staining procedures. X-gal-stained whole mounts were embedded in
paraffin, sectioned at 6.0 μm, and counterstained with nuclear fast red (Sigma-Aldrich, St Louis, MO, USA).
Primary antibodies used were rabbit-anti-Cytokeratin 8 (ab53280 1:100; Abcam, Cambridge, MA, USA),
rabbit-anti-keratin wide spectrum (Z0622 1:500; Dako, Carpinteria, CA, USA), rabbit-anti-ER alpha (sc-542 1:75;
Santa Cruz Biotechnology, USA), rabbit-anti-progesterone receptor (A0098 1:150; Dako), and mouse-anti-SMA
1A4 (1:100; Life Technologies, Carlsbad, CA, USA), anti-alpha-lactalbumin31 and anti-caseins32. IHC staining
procedure was carried out using the RTU Vectastain Universal ABC Kit and DAB peroxidase substrate kits
(Vector Laboratories, Burlingame, CA, USA) per the manufacturers protocol. All sections were counter-stained
with nuclear fast red or haematoxylin.
FISH Analysis. Dual-color FISH was performed on serial sections. Slides were de-paraffinized by three treat-

ments in xylene and then dehydrated in 100% ethanol. Slides were prepared for pepsin treatment following manufacturer’s instructions from DAKO (Histology Kit, K5599). DAKO pepsin was added at approximately 200 μl
per slide. Slides were heated to 37 °C for 10 min on Hybridizer (Abbott Molecular, Thermobrite) with lid open
using fixed temperature program. The slides were then washed in 2 × SSC, and dehydrated in an ethanol series
and allowed to dry. The chromosome paints were obtained as previously described by chromosome flow sorting33,
followed by degenerate oligonucleotide primed PCR amplification34. The flow sorted probes were labeled with
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biotin-16-dUTP and digoxigenin-dUTP. In situ hybridizations of the probes were performed using 5 μl concentrations of biotin labeled probe and DIG labeled probe. The mixture was precipitated and dissolved in 14 μl of
hybridization buffer (formamide 50%, dextran sulfate 10%, 2×SSC). The probe was denatured at 80 °C for 10 min
and reannealed at 37 °C for 90 min before hybridization. The previously prepared slide was denatured in 70% formamide/2×SSC, at 65 °C for 80 sec, and quenched in an ice-cold 70% ethanol followed by dehydration in a room
temperature 70%, 90%, and 100% ethanol series. Hybridization was carried out in a humidity chamber at 37 °C
overnight. Slides were washed and counterstained with diamidino-2-phenylindole (DAPI) (0.8 ng/μl) for 10 min
and the slides were mounted with antifade. Analyses were performed under an Axioplan 2 (Zeiss) fluorescence
microscope coupled with a CCD camera (Photometrics), and images were captured with FISHview 4.5 software
(Applied Spectral Imaging Inc., Vista, CA).

DNA Isolation and PCR. DNA was isolated from wild type mouse tail tissue, LacZ+mouse tail tissue, LA-7

rat cells, and mammary tissues using Qiagen DNeasy Blood and Tissue kit (cat # 69506 Qiagen; Valencia, CA, USA).
PCR detection was performed using the following primers: SRY primers: 5′-GCTGGGATGCAGGTGGAAAA
and 5′- CCCTCCGATGAGGCTGATATT. LacZ primers: 5′  - GGATACTGACGAAACGCCTGCC
and 5′- GATCCGCGCTGGCTACCGGC; rat actin: 5′ - GGCTTTAGGAGCTTGACAATACTG and
5′-GCATTGGTCACCTTTAGATGGA; Control primers to chromosome 1 were previously described35.
The amplified products were visualized on a 2% agarose gel containing 500 ng/mL ethidium bromide and
illuminated under ultraviolet light. Water served as a negative loading control.
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